Search for: "Bristol Myers Squibb Manufacturing Company"
Results 101 - 120
of 161
Sorted by Relevance
|
Sort by Date
24 May 2012, 4:23 am
Bristol-Myers Squibb Co., 2011 WL 2784101, at *3 (D.N.J. 2011), the Court did not hold that the warning label was enough to give notice. [read post]
6 Jun 2013, 5:00 am
Bristol-Myers Squibb Co., No. 12 Civ. 2238 (JPO), slip op. [read post]
12 Jun 2014, 10:41 am
Bristol-Myers Squibb Company v. [read post]
8 Jan 2013, 9:39 am
Bristol-Myers Squibb Co., 2013 U.S. [read post]
11 Dec 2013, 4:30 am
Bristol-Myers Squibb Co., 2013 U.S. [read post]
24 Mar 2015, 11:54 am
Xarelto, has grabbed a 32 percent market share in the highly competitive anticoagulant market, significantly ahead of Boehringer’s Pradaxa and Bristol-Myers Squibb’s Eliquis, the other two new anticoagulants in the market. [read post]
9 Jul 2015, 3:28 pm
Xarelto, has grabbed a 32 percent market share in the highly competitive anticoagulant market, significantly ahead of Boehringer’s Pradaxa and Bristol-Myers Squibb’s Eliquis, the other two new anticoagulants in the market. [read post]
18 Aug 2010, 12:19 am
(IP Whiteboard) Australia: A tale of four amendment requests: Bristol-Myers Squibb Company v. [read post]
22 Aug 2012, 7:51 am
Bristol-Myers Squibb Co., resulting in $515 million settlement arising from unlawful conduct including off-label promotion to induce government purchases of the antipsychotic drug Abilify; and United States ex rel. [read post]
3 Apr 2007, 6:20 am
(noting that "Switzerland's Serono and Germany's Schering, Altana and Schwarz were all sold in 2006" and that "Britain's Astra Zeneca and America's Wyeth and Bristol-Myers Squibb" may be the next targets for larger, acquiring firms) [read post]
2 Nov 2009, 1:24 pm
At the Wall Street Journal, Dow Jones Newswire’s Kristina Peterson addresses the Court’s denial of cert. in a drug-patent dispute between generic drug manufacturer Apotex Corp. and patent-holders Sanofi-Aventis and Bristol-Myers Squibb, while the Associated Press has coverage of the Court’s decision not to hear an appeal to stop the release of documents relating to sexual abuse lawsuits against Roman Catholic priests in… [read post]
21 Jun 2010, 9:57 am
(vi) Is it of significance in answering Question (i) that the repackaging company is indicated as the manufacturer in the package leaflet? [read post]
15 Jul 2019, 12:55 pm
There may have been a link between silicone implants (particularly ruptured ones) and auto-immune problems, and by the early 1990s, lawsuits were piling up against manufacturers of silicone implants, including Dow Corning, Baxter, and Bristol-Myers Squibb. [read post]
11 Jun 2018, 8:00 am
Supreme Court in Bristol-Myers Squibb rejected such an argument. [read post]
25 Mar 2021, 11:33 am
With Specific Jurisdiction, the Court’s recent decision in Bristol-Myers Squibb Co. v. [read post]
18 Jan 2009, 4:48 pm
Dasatinib is an anti-cancer drug belonging to the class of tyrosine kinase inhibitors first approved in the United States on June 28, 2006 and marketed by Bristol-Myer Squibb (BMS) under the brand name Sprycel. [read post]
18 Feb 2011, 11:47 am
., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
26 May 2015, 7:42 am
Bristol-Myers Squibb Co., 2011 WL 4708850 (D. [read post]
20 Mar 2009, 2:05 am
Squibb & Sons, Inc. v. [read post]
29 Sep 2008, 8:14 pm
UAEM’s Argument The general proposition that drug companies should make medicines available to low income countries at the lowest possible cost is easy to support on a humanitarian level, but the proposition may appear less realistic on a practical level: pharmaceutical research and development are costly, as is the manufacture of drugs. [read post]
